Summit Therapeutics (SMMT) Debt Ratio (2021 - 2024)

Summit Therapeutics (SMMT) has 3 years of Debt Ratio data on file, last reported at 0.57 in Q1 2024.

• Quarterly Debt Ratio rose 44.19% year-over-year to 0.57 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.57 (up 44.19% YoY) and the FY2023 annual result came in at 0.49, down 33.83% from the prior year.
• Debt Ratio grew to 0.57 in Q1 2024, from 0.49 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.74 in Q4 2022 to a low of 0.22 in Q1 2022.
• A 3-year average of 0.44 and a median of 0.42 in 2023 frame the typical range for Debt Ratio.
• The widest YoY moves for Debt Ratio: up 82.37% in 2023, down 33.83% in 2023.
• Tracing SMMT's Debt Ratio over 3 years: stood at 0.74 in 2022, then plunged by 33.83% to 0.49 in 2023, then grew by 14.8% to 0.57 in 2024.
• The last three Debt Ratio figures came in at 0.57 (Q1 2024), 0.49 (Q4 2023), and 0.42 (Q2 2023), per Business Quant data.